ArticleCanadian journal of public health = Revue canadienne de sante publique2026
Describing trends of sexually transmitted blood borne co-infections in Nova Scotia from 2019 to 2023.
Article in Canadian journal of public health = Revue canadienne de sante publique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectives(1) To describe sexually transmitted and blood-borne (STBB) co-infection events in Nova Scotia from 2019 to 2023. (2) To compare the demographics and risk factors of individuals presenting with a single STBB Infection (STBBI) vs an STBB co-infection event over the same period.
methodsWe conducted a population-based descriptive study of residents in Nova Scotia diagnosed with an STBBI between January 2019 and December 2023. Data were pulled from Panorama, Nova Scotia Public Health's information management system. Nova Scotia Surveillance Guidelines were used to define confirmed cases of each included STBBI (human immunodeficiency (HIV), hepatitis B (HBV), and hepatitis C (HCV) viruses, chlamydia, gonorrhea, and syphilis). We defined a co-infection event as infection by at least two separate STBBI pathogens within a 90-day period. We summarized demographic characteristics of individuals who experienced co-infection events and used the chi-square goodness-of-fit test to determine whether there was a significant difference in risk factor distribution compared to those who had a single STBBI (non-co-infection events).
resultsThere were 320 STBB co-infection events from 2019 to 2023, with the reported rate of 6.7 co-infections per 100,000 population in 2019 and 10.7 co-infections per 100,000 population in 2023. A chlamydia-gonorrhea co-infection event was the most prevalent STBB co-infection in Nova Scotia, representing 72% of all events over the study period.
conclusionCreating awareness of prevalent STBB co-infection events, trends, and those most susceptible to STBB co-infections within Nova Scotia is important to inform public health strategies and awareness programs.
Indexed as
Identifiers
42687101What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.